Clinical Trials Logo

Clinical Trial Summary

Today Endoscopic repair of recurrent Tracheesophageal fistula (TEF) is a safe procedure. Using Trichlosiacetic acid 50% (TCA) for endoscopic aplication of the fistula was reported with a good results ( 4 cases). There were no serious advers effects.

The investigators want to use also TCA 50% for endoscopic repair in children with recurrent TEF.


Clinical Trial Description

Today Endoscopic repair of recurrent Tracheesophageal fistula (TEF) is a safe procedure. Using Trichlosiacetic acid 50% (TCA) for endoscopic aplication of the fistula was reported with a good results ( 4 cases). There were no serious advers effects.

We want to use also TCA 50% for endoscopic repair in children with recurrent TEF. ;


Study Design

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01287312
Study type Interventional
Source Hadassah Medical Organization
Contact shlomo cohen, MD
Phone +972 2 6776817
Email shlomoco@hadassah.org.il
Status Recruiting
Phase N/A
Start date January 2011
Completion date January 2013

See also
  Status Clinical Trial Phase
Completed NCT05150600 - Inverse Ratio Ventilation in Neonatal Open Repair of Tracheoesophageal Fistula. N/A
Not yet recruiting NCT05847101 - Outcome Predictors of Trachea-esophageal Fistula
Not yet recruiting NCT04507295 - Cerebral Blood Flow in Neonates During Thoracoscopic Surgeries N/A